A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood—and it can support the cells’ growth for further analysis.
The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide. In clinics, such a device could one day help doctors diagnose cancers, give more accurate prognoses and test treatment options on cultured cells without subjecting patients to traditional biopsies.
“If we can get these technologies to work, it will advance new cancer drugs and revolutionize the treatment of cancer patients,” said Max Wicha, M.D., Distinguished Professor of Oncology and director of the U-M Comprehensive Cancer Center and co-author of a paper on the new device, published online this week in Nature Nanotechnology.
“Circulating tumor cells will play a significant role in the early diagnosis of cancer and to help us understand if treatments are working in our cancer patients by serving as a ‘liquid’ biopsy to assess treatment responses in real time,” said co-author Dr. Diane Simeone, the Lazar J. Greenfield Professor of Surgery at the U-M Medical School and director of the Translational Oncology Program.
“Studies of circulating tumor cells will also help us understand the basic biologic mechanisms by which cancer cells metastasize or spread to distant organs—the major cause of death in cancer patients.”
Yet these cells aren’t living up to their promise in medicine because they are so difficult to separate from a blood sample, the researchers say. In the blood of early-stage cancer patients, they account for less than one in every billion cells, so catching them is tougher than finding the proverbial needle in a haystack.
“I can burn the haystack or use a huge magnet,” said Sunitha Nagrath, an assistant professor of chemical engineering, who led the research. “When it comes to circulating tumor cells, they almost look like—feel like—any other blood cell.”
On their microfluidic chip, Nagrath’s team grew dense forests of molecular chains, each equipped with an antibody to grab onto cancer cells.
Even after the cells are caught, it’s still hard to run a robust analysis on just a handful of them, the researchers say. That’s why this demonstration of highly sensitive tumor cell capture, combined with the ability to grow the cells in the same device, is so promising.
Hyeun Joong Yoon, a postdoctoral researcher in the Nagrath lab with a background in electrical engineering, was instrumental in making the microfluidic chip. He started with a silicon base and added a grid of nearly 60,000 flat gold shapes, like four-petaled flowers, each no wider than a strand of hair.
The gold flowers naturally attracted a relatively new material called graphene oxide. These sheets of carbon and oxygen, just a few atoms thick, layered themselves over the gold. This layered formation allowed the team to grow the tumor-cell-catching molecular chains so densely.
“It’s almost like each graphene has many nano-arms to capture cells,” Nagrath said.
To test the device, the team ran one-milliliter samples of blood through the chip’s thin chamber. Even when they had added just three-to-five cancer cells to the 5-10 billion blood cells, the chip was able to capture all of the cells in the sample half the time, with an average of 73 percent over 10 trials.
“That’s the highest anybody has shown in the literature for spiking such a low number of cells,” Nagrath said.
The Latest Bing News on:
Liquid biopsy
- Mercy BioAnalytics to Present Results from a Large Ovarian Cancer Screening Study at the ASCO Annual Meetingon April 24, 2024 at 8:00 am
Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American Society of Clinical Oncology (ASCO) Annual ...
- Liquid biopsy firm Angle signs new commercial agreement with AstraZenecaon April 24, 2024 at 1:16 am
United Kingdom-based liquid biopsy company Angle (OTCQX:ANPCY) has signed a supplier agreement with the biopharmaceutical company AstraZeneca (NASDAQ:AZN) to tailor the existing Parsortix-based DNA ...
- SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africaon April 23, 2024 at 4:31 pm
SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, has announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® ...
- Non-Invasive Liquid Biopsy Market CAGR of 15.7%, Size, Trends, Growth Status, Share, Research, and Forecast 2024 to 2032on April 16, 2024 at 2:06 pm
Liquid biopsy has emerged as a promising non-invasive technique for detecting and monitoring various types of cancers. Unlike traditional tissue biopsies, which often involve invasive procedures, ...
- Ovarian Cancer: Another Promising Target for Liquid Biopsyon April 11, 2024 at 5:00 pm
He called liquid biopsy "a great advance" in many oncology settings, including cancer screening because finding tumors early offers the best chance at cure. However, one of the main concerns about ...
- Study suggests liquid biopsy could detect and monitor aggressive small-cell lung canceron April 10, 2024 at 11:25 am
A new lab assay developed by researchers at Fred Hutch Cancer Center could make diagnosis and treatment of small-cell lung cancer and non-small cell lung cancer easier. The work is published in the ...
- Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Canceron April 10, 2024 at 6:24 am
A new screening test raises the possibility of catching pancreatic cancer earlier, when tumors can be removed, and patients cured.
- An exosome-based liquid biopsy shows promise for early detection of pancreatic canceron April 8, 2024 at 12:00 pm
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...
- There’s still no standard test to detect pancreatic cancer early. Scientists are working to change thaton April 8, 2024 at 8:31 am
Across the United States, research teams are investigating ways to spot early cases, with many turning to blood-based liquid biopsy tests. “This term ‘liquid biopsy,’ essentially ...
- There’s still no standard test to detect pancreatic cancer early. Scientists are working to change thaton April 8, 2024 at 8:31 am
To spot breast cancer early, there are mammograms. To find colon cancer early, there are colonoscopies. But there is no standard recommended test to detect early cases of pancreatic cancer – when the ...
The Latest Google Headlines on:
Liquid biopsy
[google_news title=”” keyword=”Liquid biopsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Diagnosing cancers
- Pop musician Shawn Hook thought he may never sing again after tonsil cancer diagnosison April 25, 2024 at 1:05 am
Shawn Hook is plotting his return to pop music after a tonsil cancer diagnosis threatened to silence his singing career. The 39-year-old performer says his life was put on hold in January 2023 when he ...
- Mortality Up for Breast Cancer Diagnosed Five to <10 Years After Childbirthon April 24, 2024 at 11:30 pm
Young-onset breast cancer (YOBC) with germline BRCA pathogenic variants (PVs) is associated with an increased risk for all-cause mortality if diagnosed within 10 years after childbirth, according to a ...
- Derby dad was unaware men got breast cancer until diagnosison April 24, 2024 at 10:23 pm
A dad who was diagnosed with terminal breast cancer wants to spread awareness that men can get the disease. Geoff Sweeney, from Derby, was diagnosed with breast cancer in 2020 after discovering a lump ...
- Cincinnati woman tackling Flying Pig half marathon 1 year after cancer diagnosison April 24, 2024 at 8:28 pm
After several months of chemotherapy, Ariel is cancer-free. Now, this May, exactly one year after her cancer diagnosis, she's tackling a new challenge — her very first 10K and half marathon.
- Patrick Swayze's cancer diagnosis made his widow feel 'like a nail was being hammered into' her 'own coffin'on April 24, 2024 at 5:00 pm
Patrick Swayze's widow, Lisa Niemi Swayze, is speaking out about how she felt when she heard her late husband's cancer diagnosis.
- Young adults at highest risk of being diagnosed with colorectal canceron April 24, 2024 at 1:44 pm
Getting better sleep, exercising, diversifying your microbiome and getting regular screenings can help reduce the risks of colorectal cancer.
- Patrick Swayze's Widow Felt 'Like a Nail Was Hammered in My Own Coffin' After His Cancer Diagnosis (Exclusive)on April 24, 2024 at 1:39 pm
Lisa Niemi Swayze, who works with leading pancreatic cancer non profit PanCAN to help raise awareness for the disease in honor her late husband’s memory, reveals to PEOPLE her reaction to Patrick ...
- Zoe Ball announces mum's death after cancer diagnosison April 24, 2024 at 2:39 am
Zoe Ball's mother Julia Peckham has died following an illness with cancer, the BBC presenter has said. The BBC Radio 2 host made the announcement on X, formerly Twitter, early on Wednesday with the ...
- King Charles Honors Kate Middleton After Cancer Diagnosison April 23, 2024 at 10:45 am
King Charles III gave Princess Kate an award previously given to Winston Churchill, David Attenborough and Stephen Hawking.
- Mom and Daughter Diagnosed with Colon Cancer 10 Days Apart: ‘What on Earth Would Be the Chances?’on April 22, 2024 at 10:46 am
In the U.S., colorectal cancer is now the leading cause of cancer death for men under 50, and the second-leading cause of cancer death for women under 50, according to the American Cancer Society, ...
The Latest Google Headlines on:
Diagnosing cancers
[google_news title=”” keyword=”diagnosing cancers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]